Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

During the Trading Day
113.85 +5.36 / +4.94%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
113.85 0.00 / 0.00%
 
Volume: 19.6K

Today’s Trading

Previous close108.49
Today’s open109.80
Day’s range109.38 - 113.87
Volume1,500,207
Average volume (3 months)1,091,086
Market cap$19.6B
Dividend yield--
Data as of 3:59pm ET, 08/27/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+31.22%
Earnings growth (next 5 years)+199.00%
Revenue growth (last year)+44.10%
P/E ratio1,476.6
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+2.79+2.18%
ZTSZoetis Inc+1.61+3.64%
ENDPEndo International P...+2.62+3.43%
HSPHospira Inc+0.08+0.09%
Data as of 4:03pm ET, 08/27/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Partner Offers